Inaperisone NEW

Price	$68	$163	$263
Package	1mg	5mg	10mg

Min. Order:
Supply Ability:	10g
Update Time:	2024-11-19

Product Details

Product Name: Inaperisone	CAS No.: 99323-21-4
Purity: 99.74%	Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

Name	Inaperisone
Description	Inaperisone is a novel centrally acting muscle relaxant that inhibits the voiding reflex. Inaperisone may inhibit the voiding reflex by acting indirectly on GABAB receptors in the brainstem.
In vivo	Inaperisone (4 mg/kg i.v. ; normal and decerebrated rats) abolished rhythmic bladder contractions observed contractions.[1] The doses of intracerebroventricularly (i.c.v.) and intrathecally injected inaperisone which abolished the rhythmic bladder contractions were 10 and 100 micrograms, respectively.[1]
Storage	Shipping with blue ice.
Solubility Information	DMSO : 50 mg/mL (203.78 mM)
Inhibitors Related	Valproic acid sodium salt \| DL-Menthol \| p-Hydroxybenzaldehyde \| β-Alanine \| Penicillin G sodium salt \| Halothane \| Chlorothymol \| Piperazine citrate \| Riluzole \| Gabapentin \| Nikethamide \| (-)-α-Pinene
Related Compound Libraries	Bioactive Compound Library \| Bioactive Compounds Library Max \| Ion Channel Targeted Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.